1. No category

Annual Cancer Symposium 2015
Final Program
September 3rd to 5th, 2015
Grand Coral Beach Spa & Resort
Cancun, Mexico
Organization& Scientific Program Committee
Society of Surgical Oncology
Jeffrey Drebin, MD, PhD, FACS
President of the Society Of Surgical Oncology
Daniel G. Coit, MD, FACS
President Elect SSO
Chairman, Department of Surgery
John Rhea Barton Professor of Surgery
University of Pennsylvania Health System
Professor of Surgery
Memorial Sloan Kettering Cancer center,
New York, USA.
Suzanne Klimberg, MD
Past- President SSO
Charles M. Balch, MD
Past-President SSO
Director of the UAMS Breast Cancer Program
University of Arkansas for Medical Sciences (UAMS),
Arkansas, USA
Peter Beistch MD, FACS
Department of Breast Surgical
Oncology
Medical City Dallas Hospital
Past-President American Society of
Breast Surgeons
Professor of Surgery, University of Texas Southwestern
Medical Center,
Editor in Chief Annals Surgical of Oncology
Dallas, Texa. USA
Mitchell Posner, MD
Past-President SSO
Professor of Surgery
Surgical Oncology,
Medical Director,
Clinical Cancer Programs
University of Chicago, Chicago, ILL, USA
Eleftherios (Terry) P.
Mamounas, MD, MPH, FACS
Professor of Surgery
UF Health Cancer Center Orlando,
FL, USA.
Organization& Scientific Program Committee
Instituto Nacional de Cancerologia
Abelardo Meneses García, MD
Director General
Instituto Nacional de Cancerología
Ángel Herrera Gómez, MD
Director General Adjunto Médico
Instituto Nacional de Cancerología
Juan Enrique Bargallo Rocha,
MD
Profesor Titular Del Curso
Jefe de Departamento Tumores
Mamarios
Instituto Nacional de Cancerologia
SSO International Member
Eduardo E. Cervera Ceballos, MD
Director De Docencia
Instituto Nacional de Cancerología
Gonzalo Montalvo Esquivel, MD
Sub-Director de Cirugia
Instituto Nacional de Cancerología
Hector Martínez Said, MD
Profesor Titular Del Curso
Coordinador Clínica de
Melanoma
Instituto Nacional de
Cancerologia
SSO Executive Council
Sylvia Verónica Villavicencio
Valencia, MD
Profesor Titular Del Curso
Subdirectora de Educacion Medica
Instituto Nacional de Cancerologia
SSO International Member
FACULTY
International Professor
Jeffrey Drebin, MD, PhD, FACS
President of the Society of Surgical Oncology
University of Pennsylvania Health System
Daniel G. Coit, MD, FACS
President Elect SSO
Memorial Sloan Kettering, NY, USA.
Suzanne Klimberg, MD
University of Arkansas for Medical Sciences
Charles Balch, MD
University of Texas Southwestern Medical Center
Peter Beitsch, MD, FACS
University of Texas Southwestern Medical Center
Mitchell Posner, MD
University of Chicago, Chicago, ILL, USA
Eleftherios (Terry) P. Mamounas MD, MPH, FACS
UF Health Cancer Center Orlando, FL, USA.
Latinamerican Professors
Carlomagno Castillero Pinilla, MD
Panama, Panama
Eduardo Gharzouzi Bassila, MD
Guatemala, Guatemala
Herbert Castillo Oliva, MD
Guatemala, Guatemala
Xavier Kon Jara, MD
Portoviejo, Ecuador
National Professors
Aaron Gonzalez Enciso, MD
Instituto Nacional de Cancerología
Alberto Tavares de la Paz, MD
Hospital Regional de Alta
Especialidad del Bajío
Alejandro E. Padilla Rosciano, MD
Instituto Nacional de Cancerología
Amancio Gatica Pérez MD
Puebla, Puebla
Ángel Herrera Gómez, MD
Instituto Nacional de Cancerología
Antonio Gómez Pedraza, MD
Instituto Nacional de Cancerología
Antonio Maffuz Aziz, MD
Centro Médico ABC
Armando Medina Bojorquez M.D.
Centro Dermatológico “Dr. Ladislao de la
Pascua”
Arturo Lavín Lozano, MD
Tepic, Nayarit
Carlos G. Parra Torres MD
Instituto Nacional de Cancerología
Carlos Robles Vidal, MD
Instituto Nacional de Cancerología
Cynthia M. Villarreal Garza, MD
Instituto Nacional de Cancerología
Christian H Flores Balcázar, MD
Instituto Nacional de Cancerologia
Daniel Alcalá Pérez, MD
Sociedad Mexicana de Cirugía
Dermatológica y Oncológica
Dorian Yarih García Ortega, MD
Instituto Nacional de Cancerologia
Edgardo Jiménez Fuentes, MD
Instituto Nacional de Cancerología
Erika B. Ruiz García, MD
Instituto Nacional de Cancerología
Francisco J. Ochoa Carrillo, MD
Instituto Nacional de Cancerología
Germán Calderillo Ruiz, MD
Instituto Nacional de Cancerología
Gonzalo Montalvo Esquivel, MD
Instituto Nacional de Cancerología
Gregorio Quintero Beuló, MD
Hospital General de México
Guillermo Flores Ayala, MD
Instituto Jalisciense de Cancerología, Jalisco
Héctor Gurrola Machuca, M.D.
Centro Médico Nacional,
"20 de Noviembre" ISSSTE
Héctor Martínez Said, MD
Instituto Nacional de Cancerología
Horacio Noé López Basave, MD
Instituto Nacional de Cancerología
Itzel Vela Sarmiento, MD
Instituto Nacional de Cancerología
Javier Melchor Rúan, MD
Instituto Nacional de Cancerología
Jaime Corona Rivera, MD
Instituto Nacional de Cancerología
José Francisco Corona Cruz, MD
Instituto Nacional de Cancerología
José Luis Barrera Franco, MD
Centro Oncológico Estatal, ISSEMYM Toluca
Juan Enrique Bargalló Rocha, MD
Instituto Nacional de Cancerología
Juan Manuel Medina Castro, MD
Centro Oncológico Estatal, ISSEMYM Toluca
Juan Manuel Ruiz Molina, MD
Instituto Nacional de Cancerología
Judith Domínguez Cherit, MD
Instituto Nacional de Ciencias Médicas y
Nutrición “Dr. Salvador Zubirán”
Karla Susana Martín Téllez, MD
Instituto Nacional de Cancerología
Kuauhyama Luna Ortiz, MD
Instituto Nacional de Cancerología
Luis Manuel Domínguez Parra, MD
Hospital Regional de Alta
Especialidad de la Península
María Teresa Ramírez Ugalde, MD
Instituto Nacional de Cancerología
María Fernanda Hurtado Díaz, MD
Skin Project Center
María Teresa de J. Vega González, MD
Instituto Nacional de Cancerología
Mariela Montoya Montes de Oca, MD
Xalapa, Veracruz
Mario Cuellar Hübbe, MD
Instituto Nacional de Cancerología
Martín Granados García, MD
Instituto Nacional de Cancerología
Miguel Ángel Álvarez Avitia, MD
Instituto Nacional de Cancerología
Mónika Blake Cerda, MD
Instituto Nacional de Cancerología
Nereida Esparza Arias, MD
Instituto Nacional de Cancerología
Óscar G. Arrieta Rodríguez, MD
Instituto Nacional de Cancerología
Pabel Miranda Aguirre, MD
Centro Médico Nacional
“20 de Noviembre” ISSSTE
Paula A. Cabrera Galeana, MD
Instituto Nacional de Cancerología
Pedro Luna Pérez, MD
Hospital de Oncología
CMN Siglo XXI, IMSS
Rafael Medrano Guzmán, MD
Hospital de Oncología
CMN Siglo XXI, IMSS
Rafael Padilla Longoria, MD
Centro Médico ABC
Rafael Vásquez Córdova, MD
Instituto Nacional de Cancerología
Rafael Vázquez Romo, MD
Instituto Nacional de Cancerología
Roberto Antonio Rodríguez García, MD
Instituto Nacional de Cancerología
Rolando R. García Matus, MD
Hospital Regional de Alta
Especialidad de Oaxaca
Rubén Cortés González, MD
Instituto Nacional de Ciencias Médicas y
Nutrición “Dr. Salvador Zubirán”
Salvador Camacho Gutiérrez, MD
Guadalajara, Jalisco
Saúl E. Rodríguez Ramírez, MD
Hospital de Oncología
CMN Siglo XXI, IMSS
Seir Alfonso Cortés Cárdenas, MD
Centro Médico Nacional,
"20 de Noviembre" ISSSTE
Sylvia Verónica Villavicencio
Valencia, MD
Instituto Nacional de Cancerología
Vincenzo Aiello Crocifoglio, MD
Instituto Nacional de Cancerología
Thursday
September 3rd
CORAL KINGDOM, 2nd Floor
7:00 - 8:30 hrs
Meet the Professor Breakfast
Breast Cancer: Personalized care for early stage in
Breast Cancer
Eleftherios (Terry) P. Mamounas, MD, MPH, FACS
Professor of Surgery
UF Health Cancer Center Orlando, FL, USA.
MODERATOR:
Rafael Vázquez Romo, MD
Instituto Nacional de Cancerología
PANEL:
Suzanne Klimberg, MD
University of Arkansas for Medical Sciences (UAMS)
Amancio Gatica Pérez, MD
Puebla, Puebla
María Teresa Ramírez Ugalde, MD
Instituto Nacional de Cancerología
CORAL KINGDOM, 2nd Floor
9:00 - 10:30 hrs
Inaugural Conference
“Dr. Arturo Beltrán Ortega”
MODERATOR:
Ángel Herrera Gómez, MD
Director General Adjunto Médico
Instituto Nacional de Cancerología
“Introduction: “The Best of SSO Highlights of 6th year”
9:00 – 9:15
Héctor Martínez Said, MD
Instituto Nacional de Cancerología
SSO Executive Council
OPENING LECTURE
“The Evolution of Targeted Therapeutics in Cancer”
9:15 – 10:00
Jeffrey Drebin, MD, PhD, FACS
President of the Society of Surgical Oncology
University of Pennsylvania Health System
Panel Discussion
10:00 - 10:30
PANEL:
Charles Balch, MD
University of Texas Southwestern Medical Center, Dallas, Texas
Gonzalo Montalvo Esquivel, MD
Sub-Director de Cirugía
Instituto Nacional de Cancerología
Daniel G. Coit, MD, FACS
President Elect SSO
Professor of Surgery
Memorial Sloan Kettering Cancer Center
Francisco J. Ochoa Carrillo, MD
Instituto Nacional de Cancerología – Consejo Mexicano de
Oncología
Gregorio Quintero Beulo, MD
Sociedad Mexicana de Oncología, México
Enrique Bargallo Rocha, MD
INCan - Sociedad Mexicana de Mastología, México
CORAL KINGDOM, 2nd floor
10:30 -11:00 hrs
Best of SSO Presentations
Breast Cancer
Suzanne Klimberg, MD
University of Arkansas for Medical Sciences (UAMS)
MODERATORS:
Rafael Vazquez Romo, MD
Instituto Nacional de Cancerología
Nereida Esparza Arias, MD
Instituto Nacional de Cancerología
•
•
•
•
Targeted Axillary Dissection Improves Axillary Evaluation following Neoadjuvant
Chemotherapy in Node Positive Patients A.S. Caudle*, W. Yang, E.A. Mittendorf, D.M.
Black, M. Gilcrease, I. Bedrosian, B.P. Hobbs, R.P. Candelaria, G. Babiera, B.E. Dogan,
M.J. Lim, L. Santiago, K.K. Hunt, S. Krishnamurthy, H.M. Kuerer, Surgical Oncology,
University of Texas MD Anderson Cancer Center, Houston, Texas, UNITED STATES
Prognostic Value of Combined Clinical and Pathologic Staging Variables in Predicting
Local-regional Recurrence following Neoadjuvant Chemotherapy for Breast Cancer
M. Teshome*, S. Tucker, K.K. Hunt, E.A. Mittendorf, Surgical Oncology, University of
Texas MD Anderson Cancer Center, Houston, Texas, UNITED STATES
Anti-HER2 CD4 T-cell Immunity Strongly Correlates with Pathologic Complete
Response to Neoadjuvant Therapy in HER2+ Breast Cancer J. Datta*, S. Xu, E. Berk, L.
Lowenfeld, X. Wang, E. Fitzpatrick, D. Lewis, N. Goodman, A. DeMichele, B. Czerniecki,
Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, UNITED STATES
North American Experience with Intraoperative Radiation using Low-kilovoltage XRays for Breast Cancer: Initial Report of TARGIT-R (Retrospective) S.A. Valente*, R.D.
Tendulkar, S. Cherian, C. O'Rourke, The Cleveland Clinic, Cleveland, Ohio, UNITED
STATES|J.M. Grief, L. Bailey, Alta Bates Summit Medical Center, Bay Area Breast
Surgeons, Oakland, California, UNITED STATES|A. Pederson, Memorial University
Medical Center, Savannah, Georgia, UNITED STATES|K.P. Bethke, E.D. Donnelly,
Northwestern Memorial Hospital, Robert H. Lurie Comprehensive Cancer Center,
Chicago, Illinois, UNITED STATES|R. Rudolph, Memorial University Medical Center,
Savannah, Georgia, UNITED STATES|T. Summer, Lafayette Surgical Clinic, Lafayette,
Indiana, UNITED STATES|C. Lottich, D.L. Ross, N. Bechar, Community Physician
Network Breast Care, Community Health Network, Indianapolis, Indiana, UNITED
STATES|C. Laronga, L. Loftus, A.M. Abbott, Moffit Cancer Center, Tampa, Florida,
UNITED STATES|P. Kelemen, U. Hermanto, Ashikari Breast Center, Dobbs Ferry, New
York, UNITED STATES|N.B. Friedman, G.C. Bedi, J.E. Joh, Mercy Medical Center,
Baltimore, Maryland, UNITED STATES|W.A. Thompson, III, Trinity Medical Center ,
Birmingham, Alabama, UNITED STATES|R.A. Hoefer, The Sentara Dorothy G. Hoefer
Comprehensive Breast Center, Newport News, Virginia, UNITED STATES|V. Uhl, Alta
Bates Summit Medical Center, Bay Area Cancer Physicians , Oakland, California,
UNITED STATES
CORAL KINGDOM, 2nd Floor
11:00 -11:30 hrs
Best of SSO Presentations
Melanoma/ Soft Tissue Sarcomas
Daniel G. Coit, MD, FACS
Memorial Sloan Kettering Cancer Center
MODERATORS:
Mario Cuéllar Hübbe, MD
Instituto Nacional de Cancerología
Karla Susana Martín Téllez, MD
Instituto Nacional de Cancerología
•
•
•
•
CALM Study: A Phase II Study of a Novel Oncolytic Immunotherapeutic Agent,
CVA21, Delivered Intratumorally in Patients with Advanced Malignant Melanoma
R.H. Andtbacka*, Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake
City, Utah, UNITED STATES|B. Curti, Providence Cancer Center, Portland, Oregon,
UNITED STATES|H. Kaufman, Rutgers University, New Brunswick, New Jersey, UNITED
STATES|G.A. Daniels, UCSD Moores Cancer Center, La Jolla, California, UNITED
STATES|J.J. Nemunatitis, Mary Crowley Cancer Research Center, Dallas, Texas, UNITED
STATES|L.E. Spitler, Northern California Melanoma Center, San Francisco, California,
UNITED STATES|S. Hallmeyer, Oncology Specialists SC, Park Ridge, Illinois, UNITED
STATES|J. Lutzky, Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida,
UNITED STATES|S. Schultz, Investigative Clinical Research, Indianapolis, Indiana,
UNITED STATES|E.D. Whitman, Atlantic Melanoma Center, , Morristown, New Jersey,
UNITED STATES|K. Zhou, Pharmanet/i3, Princeton, New Jersey, UNITED STATES|J.I.
Weisberg, D. Shafren, Viralytics, Sydney, New South Wales, AUSTRALIA
Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in
Patients with Melanoma (SAFE-MILND) J.W. Jakub*, T.E. Grotz, J.B. Allred, V.J. Suman,
H. Nelson, Subspecialty General Surgery, Mayo Clinic, Rochester, Minnesota, UNITED
STATES|A.M. Terando, Ohio State University Medical Center, Columbus, Ohio, UNITED
STATES|A. Sarnaik, H. Lee Moffitt Cancer Center, Tampa, Florida, UNITED STATES|C.E.
Ariyan, M.S. Brady, Memorial Sloan Kettering Cancer Center, New York, New York,
UNITED STATES|M.B. Faries, John Wayne Cancer Center, Santa Monica, California,
UNITED STATES|H. Neuman, University of Wisconsin School of Medicine and Public
Health, Madison, Wisconsin, UNITED STATES|N. Wasif, Mayo Clinic Arizona, Phoenix,
Arizona, UNITED STATES|S. Zani, Jr., D. Tyler, Duke University Medical Center, Durham,
North Carolina, UNITED STATES|J.D. Wayne, K.Y. Bilimoria, Northwestern University
Feinberg School of Medicine, Chicago, Illinois, UNITED STATES|J.M. Farma, Fox Chase
Cancer Center, Philadelphia, Pennsylvania, UNITED STATES|B.J. Averbook,
MetroHealth Medical Center, Cleveland, Ohio, UNITED STATES
Lymphoscintigraphy Concordance with Intraoperative Findings from Sentinel Lymph
Node (SLN) Biopsy with [99mTc] Tilmanocept in Clinically Node-negative (cN0) Head
and Neck Squamous Cell Carcinoma Patients (HNSCC) D. Chepeha*, Otolaryngology,
Univeristy of Toronto - Princess Margaret Hospital , Toronto, Ontario, CANADA|A.
Agrawal, The Ohio State University, Columbus, Ohio, UNITED STATES|F.J. Civantos,
University of Miami Hospitals and Clinics, Miami, Florida, UNITED STATES|S.Y. Lai, MD
Anderson Cancer Center, Houston, Texas, UNITED STATES
Is less really more for Retroperitoneal Sarcoma? A NSQIP Analysis of 1,018 Patients
J.W. Harris*, D. Davenport, P.C. McGrath, C.D. Tzeng, General Surgery , University of
Kentucky, Lexington, Kentucky, UNITED STATES
CORAL KINGDOM, 2nd floor
11:30 -12:00 hrs
Best of SSO Presentations
Gastrointestinal Cancer
Mitchell Posner, MD
University of Chicago, Chicago, ILL, USA
MODERATORS:
Aarón González Enciso, MD
Instituto Nacional de Cancerología
Roberto Antonio Rodríguez García, MD
Instituto Nacional de Cancerología
•
•
•
•
Organ Preservation in Rectal Cancer Patients with Clinical Complete Response after
Neoadjuvant Therapy J. Smith*, O. Chow, A. Eaton, M. Widmar, G. Nash, L. Temple,
J.G. Guillem, M.R. Weiser, K.A. Goodman, A. Cercek, L.B. Saltz, M.J. Gollub, M. Gonen, J.
Garcia Aguilar, P.B. Paty, Department of Surgery, Memorial Sloan Kettering, New York,
New York, UNITED STATES
Neoadjuvant Pelvic Perfusion Provides Symptom Control and may Facilitate
Resection of Pelvic Recurrent Rectal Cancer H.J. Wanebo*, J. Belliveau, E. Gustafson,
Surgery, Landmark Medical Center, Bristol, Puerto Rico, UNITED STATES|G. Begossi,
Alta Bates Medical Center, Oakland , California, UNITED STATES
What is the Significance of Indeterminate Pulmonary Nodules in Patients undergoing
Resection for Pancreatic Adenocarcinoma? K.E. Poruk*, Y. Kim, J.L. Cameron, J. He,
F.E. Eckhauser, N. Rezaee, T.M. Pawlik, C.L. Wolfgang, M.J. Weiss, Department of
Surgery, The Johns Hopkins Hospital, Baltimore, Maryland, UNITED STATES|J. Herman,
The Johns Hopkins Hospital, Department of Radiation Oncology, Baltimore, Maryland,
UNITED STATES|D. Laheru, L. Zheng, The Johns Hopkins Hospital, Department of
Medical Oncology, Baltimore, Maryland, UNITED STATES|E.K. Fishman, The Johns
Hopkins Hospital, Department of Radiology, Baltimore, Maryland, UNITED STATES|R.H.
Hruban, The Johns Hopkins Hospital, Department of Pathology, Baltimore, Maryland,
UNITED STATES
The Optimal Length of the Proximal Resection Margin in Patients with Proximal
Gastric Adenocarcinoma: A Multi-institutional Study of the U.S. Gastric Cancer
Collaborative L.M. Postlewait*, M.H. Squires, D.A. Kooby, K. Cardona, C.A. Staley, S.K.
Maithel, Division of Surgical Oncology, Emory University, Atlanta, Georgia, UNITED
STATES|G.A. Poultsides, D.J. Worhunsky, Department of Surgery, Stanford University
Medical Center, Stanford, California, UNITED STATES|S.M. Weber, A.W. Acher, C.S.
Cho, E.R. Winslow, Department of Surgery, University of Wisconsin School of Medicine
and Public Health, Madison, Wisconsin, UNITED STATES|M. Bloomston, C.R. Schmidt,
N. Saunders, Division of Surgical Oncology, The Ohio State University Comprehensive
Cancer Center, Columbus, Ohio, UNITED STATES|R.C. Fields, L.X. Jin, Department of
Surgery, Washington University School of Medicine, Saint Louis, Missouri, UNITED
STATES|T.M. Pawlik, A. Ejaz, Department of Surgery, The Johns Hopkins Hospital,
Baltimore, Maryland, UNITED STATES|K.I. Votanopoulos, D. Swords, Department of
Surgery, Wake Forest University, Winston-Salem, North Carolina, UNITED STATES
•
•
•
•
•
•
A Simple preoperative Risk Scale Accurately Predicts perioperative Mortality
following Gastric Resection for Malignancy C.R. Harnsberger*, H.F. Fuchs, R.C.
Broderick, G.R. Jacobsen, B.J. Sandler, K. Kelly, S. Horgan, University of California, San
Diego, Department of Surgery, Center for the Future of Surgery, San Diego, California,
UNITED STATES|D.C. Chang, Massachusetts General Hospital, Harvard Medical School,
Department of Surgery, Codman Center, Boston, Massachusetts, UNITED STATES
An Externally Validated Prognostic Multigene Expression Assay for
Survival in Resected Colorectal Liver Metastases V. Balachandran*, A.
Arora, M. Gonen, T.P. Kingham, P.J. Allen, R.P. DeMatteo, W.R. Jarnagin, M.I.
D'Angelica, Surgery, Memorial Sloan Kettering Cancer Center, New York, New
York, UNITED STATES|N. Snoeren, S.V. Hooff, I.H. Borel Rinkes, University
Medical Center , Heidelberglaan, Utrecht, NETHERLANDS
Comprehensive Multiplatform Biomarker Analysis of 313 Hepatocellular
Carcinoma Identifies Potential Therapeutic Options J.T. Miura, T. Gamblin,
Medical College of Wisconsin, Milwaukee, Wisconsin, UNITED STATES| G.K.
Abou-Alfa*, C. Ang, Memorial Sloan Kettering Cancer Center, New York, New
York, UNITED STATES|A.R. He, Georgetown University Hospital, Washington,
District of Columbia, UNITED STATES|N.S. Yee, Penn State Hershey Cancer
Institute, Hershey, Pennsylvania, UNITED STATES
Comparing perioperative Processes of Care in High- and Low-mortality Centers
Performing Pancreatic Surgery C. Scally*, H. Yin, S. Wong, University of Michigan, Ann
Arbor, Michigan, UNITED STATES|J. Birkmeyer, Dartmouth-Hitchcock Medical Center,
Hanover, New Hampshire, UNITED STATES
Complete Pathologic Response is Independent of the Timing of
Esophagectomy and is Predictive of Improved Survival following
Neoadjuvant Chemoradiation for Esophageal Cancer S. Singla*, M. Kukar,
K. Attwood, H. Nava, S.J. Nurkin, B.W. Kuvshinoff, S. Hochwald, Surgical
Onclogy, Roswell Park Cancer Institute, Buffalo, New York, UNITED
STATES|R.M. Alnaji, W. Du, University at Buffalo, Buffalo, New York, UNITED
STATES
Fluid Administration is associated with Morbidity in Patients undergoing
Transhiatal Esophagectomy for Esophageal Carcinoma O.S. Eng*, R.L.
Sanders, D. Moore, C. Chen, Rutgers-Robert Wood Johnson Medical School,
New Brunswick, New Jersey, UNITED STATES|J.E. Langenfeld, D.A. August,
D.R. Carpizo, Rutgers-Cancer Institute of New Jersey, Rutgers-Robert Wood
Johnson Medical School, New Brunswick, New Jersey, UNITED STATES|
BREAK
12:00 – 12:30
CORAL KINGDOM, 2nd floor
12:30 -13:15 hrs
Interactive Multidisciplinary Case
Presentation
Colorectal cancer
CLINICAL CASE PRESENTER:
Itzel Vela Sarmiento, MD
Instituto Nacional de Cancerología
PARTICIPANTS:
Horacio Noé López Basave, MD
Instituto Nacional de Cancerología
Juan Manuel Ruiz Molina, MD
Instituto Nacional de Cancerología
Erika B. Ruiz García, MD
Instituto Nacional de Cancerología
Pedro Luna Pérez, MD
Centro Médico Nacional Siglo XXI
Mariela Montoya Montes de Oca, MD
Xalapa, Veracruz
Arturo Lavín Lozano, MD
Tepic, Nayarit
Guillermo Flores Ayala, MD
Guadalajara, Jalisco
CORAL KINGDOM, 2nd floor
13:15 -14:00 hrs
Interactive Multidisciplinary Case
Presentation
Melanoma – Sarcomas
CLINICAL CASE PRESENTER:
Dorian Yarih García Ortega, MD
Instituto Nacional de Cancerología
PARTICIPANTS:
Daniel G. Coit, MD, FACS
Memorial Sloan Kettering, NY, USA.
Charles Balch, MD
University of Texas Southwestern Medical Center
Sylvia Verónica Villavicencio Valencia, MD
Instituto Nacional de Cancerología
Miguel Ángel Álvarez Avitia, MD
Instituto Nacional de Cancerología
Alberto Tavares de la Paz, MD
Hospital Regional de Alta Especialidad del Bajío
Pabel Miranda Aguirre, MD
Centro Médico Nacional “20 de Noviembre” ISSSTE
Xavier Kon Jara, MD
Portoviejo, Ecuador
CORAL KINGDOM, 2nd floor
14:00 -14:45 hrs
Interactive Multidisciplinary Case
Presentation
Thoracic oncology
CLINICAL CASE PRESENTER:
José Francisco Corona Cruz, MD
Instituto Nacional de Cancerología
PARTICIPANTS:
Edgardo Jiménez Fuentes, MD
Instituto Nacional de Cancerología
Rafael Vázquez Córdova, MD
Instituto Nacional de Cancerología
Carlos G. Parra Torres, MD
Instituto Nacional de Cancerología
Óscar Gerardo Arrieta Rodríguez, MD
Instituto Nacional de Cancerología
Mónika Blake Cerda, MD
Instituto Nacional de Cancerología
Luis Manuel Domínguez Parra, MD
Hospital Regional de Alta Especialidad de la Península de Yucatán
Herbert Castillo Oliva, MD
Guatemala, Guatemala
BREAK
14:45 – 15:30
CORAL KINGDOM, 2nd Floor
15:30 -17:30 hrs
Great Debates in
Surgical Oncology
Sentinel lymph node biopsy should be performed on
all patients with cutaneous melanoma ≥ 1 mm thick
15:30 – 16:30
MODERATOR: Héctor Martínez Said, MD
Instituto Nacional de Cancerología.
20´
Pro:
Daniel Coit, MD
Memorial Sloan Kettering Cancer Center, NY
20´
Con:
Charles Balch, MD
University of Texas Southwestern Medical Center
20´
Discussion
Minimally invasive surgery versus open for upper
gastrointestinal cancer
16:30 – 17:30
MODERATOR
Horacio Noé López Basave, MD
Instituto Nacional de Cancerología
20´
Pro
Mitchell Posner, MD
University of Chicago, Chicago, ILL, USA
20´
Con
Jeffrey Drebin, MD, PhD, FACS
University of Pennsylvania Health System
20´
Discussion
Grand Coral III, 4th Floor
18:00 -21:00 hrs
Great Inaugural Congress
Conference
International Academic
Oncology Meeting
The Best of Society of Surgical Oncology (SSO)
The Best of American Society Clinical Oncology (ASCO)
Hemato-Oncology Conference (HOC)
Selected Topics in Radiotherapy
Palliative Care for Oncology
Selected Topics in Gynecology Oncology
Anesthesia Management and Cancer Support
Reception Cocktail & Expo Inauguration
Welcome Reception
Friday
September 4th
CORAL KINGDOM, 2nd Floor
7:00 - 8:30 hrs
Meet the Professor Breakfast
Melanoma
Melanoma therapy: What have we learned lately?
Daniel Coit, MD, FACS.
Thomas D. Jones Professor of Surgery
Chief, Section of General Surgery
Chief, Surgical Oncology
Medical Director, Clinical Cancer Programs
University of Chicago, Chicago, ILL, USA
MODERATOR:
Mario Cuéllar Hübbe, MD
Instituto Nacional de Cancerología
PANEL:
Salvador Camacho Gutiérrez, MD
Guadalajara, Jalisco
Eduardo Gharzouzi Bassila, MD
Guatemala, Guatemala
9:00 – 15:00
CORAL KINGDOM, 2nd Floor
14:30 -15:15 hrs
Interactive Multidisciplinary Case
Presentation
Advanced skin cancer
CLINICAL CASE PRESENTER:
María Teresa de J. Vega González, MD
Instituto Nacional de Cancerología
PARTICIPANTS:
Martín Granados García, MD
Instituto Nacional de Cancerología
Kuauhyama Luna Ortíz, MD
Instituto Nacional de Cancerología
Antonio Gómez Pedraza, MD
Instituto Nacional de Cancerología
Héctor Gurrola Machuca, MD
Centro Médico Nacional “20 de Noviembre” ISSSTE
Daniel Alcalá Pérez, MD
Sociedad Mexicana de Cirugía Dermatológica y Oncológica
María Fernanda Hurtado Díaz, MD
Skin Project Center
Judith Domínguez Cherit, MD
Instituto Nacional de la Nutrición “Dr. Salvador Zubirán”
Armando Medina Bojórquez M.D.
Centro Dermatológico “Dr. Ladislao de la Pascua”
CORAL KINGDOM, 2nd Floor
15:15 -16:00 hrs
Interactive Multidisciplinary Case
Presentation
Upper Gastrointestinal Cancer
CLINICAL CASE PRESENTER:
Juan Manuel Ruiz Molina, MD
Instituto Nacional de Cancerología
PARTICIPANTS:
Mitchell Posner, MD
University of Chicago, Chicago, ILL, USA
Vincenzo Aiello Crocifoglio, MD
Instituto Nacional de Cancerología
Rafael Padilla Longoria, MD
Centro Médico ABC
Alejandro E. Padilla Rosciano, MD
Instituto Nacional de Cancerología
Germán Calderillo Ruiz, MD
Instituto Nacional de Cancerología
Seir Alfonso Cortés Cárdenas, MD
Centro Médico Nacional “20 de Noviembre” ISSSTE
Juan Manuel Medina Castro, MD
Centro Oncológico Estatal, ISSEMYM Toluca
Rolando R. García Matus, MD
Hospital Regional de Alta Especialidad de Oaxaca
Rubén Cortés González, MD
Instituto Nacional de la Nutrición “Dr. Salvador Zubirán”
Carlos Lever Rosas, MD
Hospital Central Militar
CORAL KINGDOM, 2nd floor
16:00 -16:45 hrs
Interactive Multidisciplinary Case
Presentation
Breast Cancer
CLINICAL CASE PRESENTER:
Jaime Corona Rivera, MD
Instituto Nacional de Cancerología
PARTICIPANTS:
Suzanne Klimberg, MD
University of Arkansas for Medical Sciences
Terry Mamounas, MD
UF Health Cancer Center Orlando, FL, USA.
Peter Beitsch, MD, FACS
Medical City Dallas Hospital
Carlos Robles Vidal, MD
Instituto Nacional de Cancerología
Paula A. Cabrera Galeana, MD
Instituto Nacional de Cancerología
Christian H. Flores Balcázar, MD
Instituto Nacional de Cancerología
Cynthia M. Villarreal Garza, MD
Instituto Nacional de Cancerología
Patricia Villarreal Colín, MD
Instituto Nacional de Cancerología
Antonio Maffuz Aziz, MD
Centro Médico ABC
Gregorio Quintero Beulo, MD
Sociedad Mexicana de Oncología, México
CORAL KINGDOM, 2nd floor
17:00 -18:30 hrs
The Best of SSO
Closing Conference
GREAT DEBATES IN BREAST CANCER
MODERATORS:
Peter Beitsch, MD, FACS
Medical City Dallas Hospital
Juan Enrique Bargalló Rocha, MD
Instituto Nacional de Cancerología, México
Topic:
10´
Management of DCIS: Are we overtreating?
Yes
Charles Balch, MD
University of Texas Southwestern Medical Center
10´
No
Terry Mamounas, MD
UF Health Cancer Center Orlando, FL, USA.
10´
Discussion
Topic:
Margin width in breast conserving surgery: No
ink on tumor?
10´
Yes
Terry Mamounas, MD
UF Health Cancer Center Orlando, FL, USA.
10´
No
Suzanne Klimberg, MD
University of Arkansas for Medical Sciences
10´
Discussion
Topic:
Is sentinel lymph node biopsy accurate for
staging after chemotheraphy in patients with
initial node positive disease?
10´
Yes
Charles Balch, MD
University of Texas Southwestern Medical Center
10´
No
Suzanne Klimberg MD
University of Arkansas for Medical Sciences
10´
Discussion
19:30 – 21:00 hrs
Socialize with collegues in your disease track in a casual
Happy Hour
Saturday
September 5th
CORAL KINGDOM, 2nd Floor
7:00 - 8:30 hrs
Meet the Professor Breakfast
Gastrointestinal cancer
Multimodality therapy: Which Approach is Best for
Borderline Resectable Pancreatic Cancer?
Mitchell Posner, MD
Thomas D. Jones Professor of Surgery
Chief, Section of General Surgery
Chief, Surgical Oncology
Medical Director, Clinical Cancer Programs
University of Chicago, Chicago, ILL, USA
MODERATOR:
Javier Melchor Ruan, MD
Instituto Nacional de Cancerología
PANEL:
Saúl E. Rodríguez Ramírez, MD
Centro Médico Nacional Siglo XXI, IMSS
Carlomagno Castillero Pinilla, MD
Panamá, Panamá
9:00 – 15:00
Meeting
Grupo de Investigación en Sarcomas de México
4ª. Reunion del Consenso Nacional
09:00 - 10:00 hrs
MODERATOR:
Hector Martínez Said, MD
Instituto Nacional de Cancerología
PANEL:
Mario Cuellar Hübbe, MD
Instituto Nacional de Cancerología
José Francisco Corona Cruz, MD
Instituto Nacional de Cancerología
Sylvia Verónica Villavicencio Valencia, MD
Instituto Nacional de Cancerología
José Luis Barrera Franco, MD
Centro Oncológico Estatal, ISSEMYM, Toluca
Rafael Padilla Longoria, MD
Centro Médico ABC
Rafael Medrano Guzmán, MD
Centro Médico Nacional Siglo XXI, IMSS
Pabel Miranda Aguirre, MD
Centro Médico Nacional “20 de Noviembre” ISSSTE
Alberto Tavares de la Paz, MD
Hospital Regional Alta Especialidad del Bajío, Leon,
Guanajuato
Top Minds. Topical Education.
SSO 2016 offers you access to top minds and topical education—two key reasons to attend the
69th SSO Annual Cancer Symposium. SSO 2016 connects you with the who’s who of the
surgical oncology community as together you explore advancements in the treatment of surgical
patients with solid tumors. Additionally, the Symposium delivers an education program that is
unique in its ability to cover a broad range of important, timely and in-depth topics in one
exceptional setting.
•
Engage with esteemed colleagues from March 2-5, 2016, at the John B. Hynes
Veterans Memorial Convention Center, Boston, MA
•
Join 1,700 of the brightest minds in surgical oncology from all around the world
•
Gain advanced knowledge, expanding your insight and exposure to the newest ideas
through a multitude of presentations and workshops, many led by internationally
recognized experts
•
Connect and collaborate with old friends and new as you network between sessions,
during scheduled symposium activities, and at lively informal gatherings throughout the
event
•
Learn from two Plenary Sessions, providing you with knowledge that will inspire and
invigorate you, given by authors of the “best-of-the-best” selected abstracts
•
Exposure and access to more than 350 compelling and thought-provoking poster
sessions, along with late-breaking videos showcased in the Exhibit Hall, beginning
Thursday evening during the welcome reception through Saturday at Noon
•
Experience first-hand interaction with the latest, most advanced medical equipment,
services, and solutions for surgical oncologists – exhibited by the leading companies in
surgical oncology and the treatment of solid tumor cancers
Top People
As with every year, the 1,700+ expected SSO 2016 attendees are comprised of both
academic and community practitioners from all surgical oncology specialties, treating all
disease sites, including: Breast, Colorectal, Endocrine, Gastrointestinal, Head and Neck,
Liver and Pancreas, Melanoma and Sarcoma